{"text": ["52-Week", "Company", "Lows"], "created_at": "2019-10-07 16:18:21"}
{"text": ["Thermo", "Fisher", "Closes", "API", "Site", "Buyout,", "Fortifies", "Pharma", "Unit"], "created_at": "2019-10-07 14:17:02"}
{"text": ["Novo", "Nordisk", "Focuses", "on", "Pipeline", "Development", "Amid", "Competition"], "created_at": "2019-10-07 13:08:01"}
{"text": ["Lilly's", "CYRAMZA\u00ae", "(ramucirumab)", "Phase", "3", "Data", "in", "First-Line", "EGFR-Mutated", "Non-Small", "Cell", "Lung", "Cancer", "Published", "in", "The", "Lancet", "Oncology"], "created_at": "2019-10-07 10:45:00"}
{"text": ["FDA", "approves", "Pfenex's", "osteoporosis", "therapy"], "created_at": "2019-10-07 10:00:17"}
